ArticleEye (London, England)2012

Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study.

S Calleja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.